Osteoarthritis and Cartilage
Volume 16, Issue 2 , Pages 137-162 , February 2008

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

Received 19 December 2007 ,Accepted 20 December 2007.

References 

  1. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001 Feb;60:91–97(See comment, Review, 45 refs)
  2. Dawson J, Linsell L, Zondervan K, Rose P, Randall T, Carr A, et al. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology. 2004;43:497–504
  3. Dunlop DD, Manheim LM, Song J, Chang RW. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum. 2001;44:212–221
  4. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981–1000
  5. The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. Available from: www agreecollaboration org2006;
  6. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44:1271–1278
  7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  8. Hedges LV. Fitting continues models to effect size data. J Educ Stat. 1982;7:245–270
  9. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452–454
  10. Kleinbaum DG, Kuppler LL, Morgenstern H. Epidemiologic Research – Principles and Quantitative Methods. John Willey & Sons, Inc.; 1982;
  11. Lau J, Ioannidis JPA, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;1(127):820–826
  12. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 27 Feb 1999;318(7183):593–596(Review, 17 refs)
  13. Petrella RJ, Bartha C. Home based exercise therapy for older patients with knee osteoarthritis: a randomised controlled trial. J Rheumatol. 2000;27:2215–2221
  14. Roddy E, Zhang W, Doherty M. Aerobic walking or strengthening exercise for osteoarthritis of the knee? A systematic review. Ann Rheum Dis. 2005;64:544–548
  15. Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage. 2005;13:20–27
  16. Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, Sevick MA, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum. 2004;50:1501–1510
  17. Warsi A, LaValley MP, Wang PS, Avorn J, Solomon DH. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum. 2003;48:2207–2213
  18. Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143:427–438
  19. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004;164:1641–1649
  20. Chodosh J, Morton SC, Suttorp MJ, Shekelle PJ. Self-management education for osteoarthritis. Ann Intern Med. 2006;144:618
  21. WH Ettinger, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness, Arthritis and Seniors Trial (FAST). JAMA. 1997;277:25–31
  22. Rejeski WJ, Brawley LR, Ettinger W, Morgan T, Thompson C. Compliance to exercise therapy in older participants with knee osteoarthritis: implications for treating disability. Med Sci Sports Exerc. 1997;29:977–985
  23. O'Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised, controlled trial. Ann Rheum Dis. 1999;58:15–19
  24. Belza B, Topolski T, Kinne S, Patrick DL, Ramsey SD. Does adherence make a difference? Results from a community-based aquatic exercise program. Nurse Res. 2002;51:285–291
  25. Thomas KS, Muir KR, Doherty M, Jones AC, O'Reilly SC, Bassey EJ. Home-based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ. 2002;325:752–755
  26. Weinberger M, Tierney WM, Booher P, Katz BP. Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial. Arthritis Rheum. 1989;32:1577–1583
  27. Rene J, Weinberger M, Mazzuca SA, Brandt KD, Katz BP. Reduction of joint pain in patients with knee osteoarthritis who have received monthly telephone calls from lay personnel and whose medical treatment regimens have remained stable. Arthritis Rheum. 1992;35:511–515
  28. Weinberger M, Tierney WM, Booher P, Katz BP. The impact of increased contact on psychosocial outcomes in patients with osteoarthritis: a randomized, controlled trial. J Rheumatol. 1991;18:849–854
  29. Mazzuca SA, Brandt KD, Katz BP, Chambers M, Byrd D, Hanna M. Effects of self-care education on the health status of inner city patients with osteoarthritis of the knee. Arthritis Rheum. 1997;40:1466–1474
  30. Keefe FJ, Caldwell DS, Williams DA, Gil KM, Mitchell D, Martinez S, et al. Pain coping skills training in the management of osteoarthritis knee pain. II Follow-up results. Behav Ther. 1990;21:435–447
  31. Fransen M, Crosbie J, Edmonds J. Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial. J Rheumatol. 2001;28:156–164
  32. Deyle GD, Henderson NE, Matekel RL, Ryder MG, Garber MB, Allison SC. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med. 2000;132:173–181
  33. Deyle GD, Allison SC, Matekel RL, Ryder MG, Stang JM, Gohdes DD, et al. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther. 2005;85:1301–1317
  34. Quilty B, Tucker M, Campbell R, Dieppe P. Physiotherapy, including quadriceps exercises and patellar taping, for knee osteoarthritis with predominant patello-femoral joint involvement: randomized controlled trial. J Rheumatol. 2003;30:1311–1317
  35. Bennell KL, Hinman RS, Metcalf BR, Buchbinder R, McConnell J, McColl G, et al. Efficacy of physiotherapy management of knee joint osteoarthritis: a randomized, double-blind, placebo controlled trial. Ann Rheum Dis. 2005;64:906–912
  36. Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrell F, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee—the MOVE consensus. Rheumatology (Oxford). 2005;44:67–73
  37. Cochrane T, Davey RC, Matthes Edwards SM. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. Health Technol Assess. 2005;9(31):iii–iiv
  38. Stener-Victorin E, Kruse-Smidje C, Jung K. Comparison between electro-acupuncture and hydrotherapy, both in combination with patient education and patient education alone, on the symptomatic treatment of osteoarthritis of the hip. Clin J Pain. 2004;20:179–185
  39. Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007;66:433–439
  40. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, van Baar ME, Velhaar JA, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology (Oxford). 2002;41:1155–1162
  41. Chan GNY, Smith AW, Kirtley C, Tsang WWN. Changes in knee moments with contralateral versus ipsilateral cane usage in females with knee osteoarthritis. Clin Biomech. 2005;20:396–404
  42. Blount WP. Don't throw away the cane. J Bone Joint Surg Am. 1956;38-A:695–708
  43. Van der Esch M, Heijmans M, Dekker J. Factors contributing to the possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 2003;49:838–842
  44. Brouwer RW, Jakma TS, Verhagen AP, Verhaar JA, Bierma-Zeinstra SM. Braces and orthoses for treating osteoarthritis of the knee. Cochrane Database Syst Rev. Jan 2005;25(1):CD004020
  45. Kirkley A, Webster-Bogaert S, Litchfield R, Amendola A, Macdonald A, McCalden R, et al. The effect of bracing on varus gonarthrosis. J Bone Joint Surg Am. 1999;81:539–548
  46. Ogata K, Yasunaga M, Nomiyama H. The effect of wedged insoles on the thrust of osteoarthritic knees. Int Orthop. 1997;21:308–312
  47. Sasaki T, Yasuda K. Clinical evaluation of the treatment of osteoarthritic knees using a newly designed wedged insole. Clin Orthop Relat Res. 1987;221:181–187
  48. Keating EM, Faris PM, Ritter MA, Kane J. Use of lateral heel and sole wedges in the treatment of medial osteoarthritis of the knee. Orthop Rev. 1993;22:921–924
  49. Toda Y, Segal N, Kato A, Yamamoto S, Irie M. Effect of a novel insole on the subtalar joint of patients with medial compartment osteoarthritis of the knee. J Rheumatol. 2001;28:2705–2710
  50. Maillefert JF, Hudry C, Baron G, Kieffert P, Bourgeois P, Lechevalier D, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomized controlled study. Osteoarthritis Cartilage. 2001;9:738–745
  51. Pham T, Maillefert JF, Hudry C, Kieffert P, Bourgeois P, Lechevalier D, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis. A two-year prospective randomized controlled study. Osteoarthritis Cartilage. 2004;12:46–55
  52. Dieppe P, Buckwalter JA. Management of limb joint osteoarthritis. In:  Klippel JH,  Dieppe PA editor. Rheumatology. 2nd edn.. London, Philadelphia, St Louis, Sydney, Tokyo: Mosby; 1998;p. 8.9.1
  53. Brosseau L, Yonge KA, Robinson V, Marchand S, Judd M, Wells G, et al. Thermotherapy for treatment of osteoarthritis. Cochrane Database Syst Rev. 2003;(4):CD004522
  54. Yurtkuran M, Kocagil T. TENS, electroacupuncture and ice massage: comparison of treatment for osteoarthritis of the knee. Am J Acupunct. 1999;27:133–140
  55. Clarke RG, Willis LA, Stenner L, Nichols PJR. Evaluation of physiotherapy in the treatment of osteoarthritis of the knee. Rheumatol Rehabil. 1974;13:190–197
  56. Osiri M, Welch V, Brosseau L, Shea B, McGowan J, Tugwell P, et al. Transcutaneous electrical nerve stimulation for knee osteoarthritis. Cochrane Database Syst Rev. 2000;(4):CD002823
  57. Brosseau L. Efficacy of transcutaneous electrical nerve stimulation for osteoarthritis of the lower extremities: a meta-analysis. Phys Ther Rev. 2004;9:213–233
  58. Bjordal JM, Johnson MI, Lopes-Martins RAB, Bogen B, Chow R, Llunggren AE. Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials. BMC Musculoskelet Disord. 2007;8:51
  59. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. Pain. 2003;4:109–121
  60. Witt C, Selim D, Reinhold T, Jena S, Brinkhaus B, Liecker B, et al. Cost-effectiveness of acupuncture in patients with headache, low back pain and osteoarthritis of the hip and the knee. Focus Alternative Compl Ther. 2005;10(Suppl 1):57–58(12th Annual Symposium on Complementary Health Care – Abstracts, 19–21 September 2005, Exeter, UK)
  61. Ezzo J, Hadhazy V, Birch S, Lixing L, Kaplan G, Hochberg M, et al. Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2001;44:819–825
  62. Foster NE, Thomas E, Barlas P, Hill JC, Young J, Mason E, et al. Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. BMJ. 2007;(On line)
  63. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669–681
  64. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–1155(Review, 82 refs)
  65. Case JP, Baliunas AJ, Black JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo controlled comparison trial wit diclofenac sodium. Arch Intern Med. 2003;163:169–178
  66. Garcia Roderiguez LA, Hernandez-Diaz S. Risk of upper gastrointestinal complications among users of acetaminophen and non-steroidal anti-inflammatory drugs. Epidemiology. 2001;12:570–576
  67. Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum. 2002;46:3046–3054
  68. Towheed TE, Hochberg MC, Judd MG, Wells G. Acetaminophen for osteoarthritis. The Cochrane Libr (Oxford). 2002;(4):ID #CD004257
  69. Zhang W, Jones A, Doherty M. Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis. 2004;63:901–907
  70. Towheed TE, Maxwell L, Judd MG, Catton M, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;(1):CD004257
  71. Lewis SC, Langman MJS, Laporte J-R, Matthres NS, Rawlins MD, Wiholm B-E. Dose–response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002;54:320–326
  72. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA. 2001;286(3):315–321
  73. Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001;345:1801–1808
  74. TNS/arthritis care survey. Available from: www.arthritiscare.org.uk/OANation2003;
  75. Bjordal JM, Ljunggren AE, Klovning A, Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ. 2004;329:1317–1320
  76. Angst F, Aesclimann A, Michel BA, Stucki G. Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol. 2002;29:131–138
  77. Tramer MR, Moore RA, Reynolds DJ, McQuay HJ. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain. 2000;85:169–182
  78. Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol. 2002;29:804–812
  79. Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ. 2004;329:948–952
  80. Capurso L, Koch M. Prevention of NSAID-induced gastric lesions: H2 antagonists or misoprostol? A meta-analysis of controlled clinical studies. (In Italian) Clin Ter. 1991;139:179–189
  81. Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, et al Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet. 2004;364:665–674
  82. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352:1092–1102
  83. Hernandez-Diaz S, Varas-Lorenzo C, Garcia Rodriguez LA. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol. 2006;98:266–274
  84. Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med. 2006;99:132–140
  85. Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364:2021–2029
  86. Aldington S, Shirtcliffe P, Weatherall M, Beasley R. Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J. 2005;118:U1766
  87. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono P. Do selective cyclo-oxygenase inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332:1302–1308
  88. EMEA/CHMP/410051/2006.
  89. Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical NSAIDs in the treatment of osteoarthritis: a meta-analysis of randomized controlled trials. Chin J Evid Based Med. 2005;5(9):667–674
  90. Egger M, Smith JD, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ. 1997;315:629–634
  91. Biswal S, Medhi B, Panhi P. Long-term efficacy of nonsteroidal anti-inflammatory drugs in knee osteoarthritis: meta-analysis of randomized placebo controlled trials. J Rheumatol. 2006;33:1841–1844
  92. Evans JMM, McMahon AD, McGilchrist MM, White G, Murray FE, McDevitt DG, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case–control study. BMJ. 1995;311:22–26
  93. Baron R. Capsaicin and nociception: from basic mechanisms to novel drugs. Lancet. 2000;356:785–787
  94. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol. 1994;46:517–522
  95. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther. 1991;13:383–395
  96. Miller JH, White J, Norton TH. The value of intra-articular injections in osteoarthritis of the knee. J Bone Joint Surg Br. 1958;40:636–643
  97. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. The Cochrane Libr (Oxford). 2005;(4):ID #CD005328
  98. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. The Cochrane Libr (Oxford). 2006;(2):ID #CD005328
  99. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis. 1995;54:379–381
  100. Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil. 1980;19:212–217
  101. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis. 1996;55:829–832
  102. Valtonen EJ. Clinical comparison of triamcinolonehexacetonide and betamethasone in the treatment of osteoarthrosis of the knee joint. Scand J Rheumatol Suppl. 1981;41:1–7
  103. Flanagan J, Casale FF, Thomas DL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl. 1988;70:156–157
  104. Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intra-articular corticosteroid injection: pain relief in osteoarthritis of the hip?. J Rheumatol. 2004;31:2265–2268
  105. Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis. 1997;56:476–480
  106. Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose–response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology (Oxford). 2007;46:285–291
  107. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M. Importance of placement of intra-articular steroid injections. BMJ. 1993;307:1329–1330
  108. Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290:3115–3121
  109. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172:1039–1043
  110. Medina JM, Thomas A, Denegar CR. Knee osteoarthritis: should your patient opt for hyaluronic acid injection?. J Fam Pract. 2006;58:669–675
  111. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006 April 19th;(2):CD005321
  112. Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan//hylan in osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:1424–1436
  113. Jadad AR, Cook DJ, Browman GP. A guide to interpreting discordant systematic reviews. CMAJ. 1997;156:1411–1416
  114. The GRADE Working Group . Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490–1494
  115. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86:538–545
  116. Modowai A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract. 2005;54:758–767
  117. Conrozier T, Vignon E. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?. Clin Exp Rheumatol. 2005;23:711–716
  118. Fernandez Lopez JC, Ruana-Ravina A. Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2006;14:1306–1311
  119. Van den Bekerom MPJ, Lamme B, Sermon A, Mulier M. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg. 2007;
  120. Tikiz C, Unlu Z, Sener A, Efe M, Tuzun C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol. 2005;24:244–250
  121. Quistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid and isotonic saline. Osteoarthritis Cartilage. 2006;14:163–170
  122. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States 2002. Adv Data. May 27 2004;(343):1–19
  123. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Libr (Oxford). 2005;(4):ID #CD002946
  124. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster J-Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163:1514–1522
  125. Vlad SC, La Valley MP, McAlindon TE, Felson DT. Glucosamine for pain in osteoarthritis. Why do trial results differ?. Arthritis Rheum. 2007;56:2267–2277
  126. Higgins JP, Simon GT, Deeks JJ, Altman RD. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  127. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulphate and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808
  128. Herrero-Beaumont G, Roman Ivorra JA, del Carmen Trabado MC, Blanco FJ, Benito P, Martin-Mola E, et al. Glucosamine sulphate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555–567
  129. Leeb BF, Schweizer M, Montag K, Smolen J. A meta-analysis of chondroitin sulphate in the treatment of osteoarthritis. J Rheumatol. 2000;27:205–211
  130. McAlindon TE, La Valley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469–1475
  131. Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146:580–590
  132. Kahan A. STOPP (study on osteoarthritis progression prevention): a new two year trial with chondroitin 4 & 6 sulphate (CS). www.ibsa-ch.com/eular 2006 amsterdam vignon-2pdf (accessed on 18 September 2006).
  133. Mazieres B, Hucher MMH, Zam MMZ. Chondroitin sulphate in the treatment for knee osteoarthritis: a randomized, double-blind, multi center, placebo-controlled trial. Ann Rheum Dis. 2006;65(Suppl II):398
  134. Reginster JY, Deroisy R, Rovati LC. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet. 2001;357:251–256
  135. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giocovelli G, Rovati LC. Glucosamine sulphate use and delay of progression of knee osteoarthritis. Arch Intern Med. 2002;162:2113–2123
  136. Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three year, placebo-controlled trial. Evaluation of the chondromodulating effect of diacerein in OA of the hip. Arthritis Rheum. 2001;44:2539–2547
  137. Fidelix TS, Soares BG, Treviani VF. Diacerein for osteoarthritis. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005117
  138. Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD 101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63:1611–1617
  139. Kalso E, Edwards JE, Moore RA, McQuay H. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372–380
  140. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic non-cancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–1594
  141. Abasolo L, Carmona L. Systematic review: are major opioids effective in the treatment of musculoskeletal pain?. Med Clin (Barc). 2007;128:291–301
  142. Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2007;15:957–965
  143. De Craen AJM, Di Giulio G, Lampe-Schoenmaeckers AJEM, Kessels AGH, Kleijnen J. Analgesic efficacy and safety of paracetamol–codeine combinations versus paracetamol alone: a systematic review. BMJ. 1996;313:321–325
  144. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind?. Pain. 2004;109:207–209
  145. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 180 vs. 2000. Pain. 2004;109:514–519
  146. Hutchinson K, Moreland AME, Williams AC de C, Weinman J, Horne R. Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners. Eur J Pain. 2007;11:93–98
  147. Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med. 1990;323:725–731
  148. Harris WH, Sledge CB. Total hip and total knee replacement (2). N Engl J Med. 1990;323:801–807
  149. Ethgen O, Bruyere O, Richy F, dardennes C, Reginster J-Y. Health-related quality of life in total hip and total knee arthroplasty: a qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004;86:963–974
  150. Fitzpatrick R, Shortall E, Sculpher M, Murray D, Morris R, Lodge M, et al. Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technol Assess. 1998;2:1–64
  151. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following unicompartmental or bicompartmental knee arthroplasty. A meta-analysis. J Arthroplasty. 1995;10:141–150
  152. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental knee arthroplasty. A meta-analysis. JAMA. 1994;271:1349–1357
  153. Soderman P, Malchau H, Herberts P, Zugner R, Regner H, Garellick G. Outcome after total hip arthroplasty: Part II. Disease-specific follow-up and the Swedish National Total Hip Arthroplasty Register. Acta Orthop Scand. 2001;72:113–119
  154. Rand JA, Trousdale RT, Ilstrup DM, Harmsen WS. Factors affecting the durability of primary total knee prostheses. J Bone Joint Surg Am. 2003;85:259–265
  155. Wiklund I, Romanus B. A comparison of quality of life before and after arthroplasty in patients who had arthrosis of the hip joint. J Bone Joint Surg Am. 1991;73:765–769
  156. O'Boyle CA, McGee H, Hickey A, O'malley K, Joyce CR. Individual quality of life in patients undergoing hip replacement. Lancet. 1992;339:1088–1091
  157. Nilsdotter AK, Aurell Y, Siosteen AK, Lohmander LS, Roos HP. Radiographic stage of osteoarthritis or sex of the patient does not predict 1-year outcome after total hip arthroplasty. Ann Rheum Dis. 2001;60:228–232
  158. Nilsdotter AK, Petersson IF, Roos EM, Lohmander LS. Predictors of patient-relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis. 2003;62:923–930
  159. Lingard EA, Katz JN, Wright EA, Sledge CB, Kinemax Outcomes Group . Predicting the outcome of total knee arthroplasty. J Bone Joint Surg Am. 2004;86:2179–2186
  160. Quintana JM, Arostegui I, Azkarate J, Goenaga JI, Elexpe X, Letona J, et al. Evaluation of explicit criteria for total hip replacement. J Clin Epidemiol. 2000;53:1200–1208
  161. Escobar A, Quintana JM, Arostegui I, Azkarate J, Guenaga JI, Arenaza JC, et al. Development of explicit criteria for total knee replacement. Int J Technol Assess Health Care. 2003;19:57–70
  162. Park RE, Fink A, Brook RH, Chassin MR, Kahn KL, Merrick NJ, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health. 1986;76:766–772
  163. Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J, Goenaga JI, et al. Health-related quality of life and appropriateness of knee or hip joint replacement. Arch Intern Med. 2006;166:220–226
  164. Rasanen P, Paavolainen P, Sintonen H, Koivisto A-M, Blom M, Ryynanen O-P, et al Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop. 2007;78:108–115
  165. Ledingham J, Regan M, Jones A, Doherty M. Radiographic patterns and associations of osteoarthritis of the knee in patients referred to hospital. Ann Rheum Dis. 1993;52:520–526
  166. Griffin T, Rowden L, Morgan D, Atkinson R, Woodruff P, Maddern G. Unicompartmental knee arthroplasty for the treatment of unicompartmental osteoarthritis: a systematic study. ANZ J Surg. 2007;77:214–221
  167. Weale AE, Murray DW, Newman JH, Ackroyde CE. The length of the patellar tendon after unicompartmental and total knee replacement. J Bone Joint Surg Br. 1999;81:790–795
  168. Brand RA. Hip osteotomies: a biomechanical consideration. J Am Acad Orthop Surg. 1997;5:282–291
  169. Millis MB, Kim YJ. Rationale for osteotomy and related procedures for hip preservation: a review. Clin Orthop Relat Res. 2002;405:108–121
  170. Hasegawa Y, Iwase T, Kitamura S, Yamauchi KK, Sakano S, Iwata H. Eccentric rotational acetabular osteotomy for acetabular dysplasia: follow up of one hundred and thirty two hips for five to ten years. J Bone Joint Surg Am. 2002;84:404–410
  171. Siebenrock KA, Leunig M, Ganz R. Periacetabular osteotomy: the Bernese experience. J Bone Joint Surg Am. 2001;83:449–455
  172. Koulouvaris P, Stafylas K, Aznaoutoglou C, Zacharis K, Xenakis T. Isolated varus intertrochanteric osteotomy for hip dysplasia in 52 patients: long-term results. Int Orthop (SICOT). 2007;31:193–198
  173. Jackson JP, Waugh W. Tibial osteotomy for osteoarthritis of the knee. J Bone Joint Surg Br. 1961;43:746–751
  174. Harris WR, Kostiuk JP. High tibial osteotomy for osteoarthritis of the knee. J Bone Joint Surg Am. 1970;52:330–336
  175. Shaw JA, Moulton MJ. High tibial osteotomy: an operation based on a spurious mechanical concept. Am J Orthop. 1996;25:429–436
  176. Virolainen P, Aro HT. High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. Arch Orthop Trauma Surg. 2004;124:258–261
  177. Insall JN, Dorr D, Scott RD, Scott WN. Rationale of the knee society clinical rating system. Clin Orthop. 1999;248:13–14
  178. Burman MS, Finkelstein H, Mayer L. Arthroscopy of the knee joint. J Bone Joint Surg Am. 1934;16:255–268
  179. Rand JA. Arthroscopic management of degenerative meniscus tears in patients with degenerative arthritis. Arthroscopy. 1985;1:253–258
  180. Baumgaetner MR, Cannon WD, Vittori JM, Schmidt ES, Maurer RC. Arthroscopic debridement of the arthritic knee. Clin Orthop Relat Res. 1990;253:197–202
  181. Mclaren AC, Blokker CP, Fowler PJ, Roth JN, Rock MG. Arthroscopic debridement of the knee for osteoarthrosis. Can J Surg. 1991;34:595–598
  182. Ogilvie-Harris DJ, Fitzialos DP. Arthroscopic management of the degenerative knee. Arthroscopy. 1991;7:161–167
  183. Yang SS, Nisonson B. Arthroscopic surgery of the knee in the geriatric patient. Clin Orthop Relat Res. 1995;316:50–58
  184. Day B. The indications for arthroscopic debridement for osteoarthritis of the knee. Orthop Clin North Am. 2005;36:413–417
  185. Hubbard MJ. Articular debridement versus washout for degeneration of the medial femoral condyle. J Bone Joint Surg Br. 1996;78:217–219
  186. Merchan EC, Galindo E. Arthroscope-guided surgery versus nonoperative treatment for limited degenerative osteoarthritis of the femorotibial joint over 50 years of age: a prospective comparative study. Arthroscopy. 1993;9:663–667
  187. Ike RW, Arnold WJ, Rothschild EW, Shaw HL. Tidal irrigation versus conservative medical management in patients with osteoarthritis of the knee: a prospective randomized study. Tidal Irrigation Cooperating Group. J Rheumatol. 1992;19:772–779
  188. Livesley PJ, Doherty M, Needoff M, Moulton A. Arthroscopic lavage of osteoarthritic knees. J Bone Joint Surg Br. 1991;73:922–926
  189. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykenall DH, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81–88
  190. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594–1602
  191. Chambers K, Schulzer M, Sobelov B. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. Arthroscopy. 2002;18:683–687
  192. Siparsky P, Ryzewicz M, Peterson B, Bartz R. Arthroscopic treatment of osteoarthritis of the knee: are there any evidence-based indications?. Clin Orthop Relat Res. 2007;455:107–112
  193. Conway JD, Mont MA, Bezwada HP. Arthrodesis of the knee. J Bone Joint Surg Am. 2004;86:835–848
  194. Wasielewski RC, Barden RM, Rosenberg AG. Results of different surgical procedures on total knee arthroplasty infections. J Arthroplasty. 1996;11:931–938
  195. Wilde AH, Stearns KL. Intramedullary fixation for arthrodesis of the knee after infected total knee arthroplasty. Clin Orthop Relat Res. 1989;24:887–892
  196. Behr JT, Chmell SJ, Schwartz CM. Knee arthrodesis for failed knee arthroplasty. Arch Surg. 1985;120:350–354
  197. Hak DJ, Lieberman JR, Finerman GA. Single plane and biplane external fixators for knee arthrodesis. Clin Orthop Relat Res. 1995;316:134–144
  198. Knutson K, Hovelius L, Lindstrand A, Lidgren L. Arthrodesis after failed knee arthroplasty. A nationwide multicenter investigation of 91 cases. Clin Orthop Relat Res. 1984;191:202–211
  199. Damron TA, McBeath AA. Arthrodesis following failed total knee arthroplasty: comprehensive review and meta-analysis of recent literature. Orthopedics. 1995;18:361–368
  200. Benson ER, Resine ST, Lewis CG. Functional outcome of arthrodesis for failed total knee arthroplasty. Orthopedics. 1998;21:875–879
  201. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000;43:1905–1915
  202. Pencharz JN, Grigoriadis E, Jansz GF, Bombardier C. A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis. Arthritis Res. 2002;4:36–44(Review, 33 refs)
  203. Roddy E, Doherty M. Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different?. Rheum Dis Clin North Am. 2003;29:717–731
  204. Wegman A, van der WD, van Tulder M, Stalman W, de Vries T. Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol. 2004;31:344–354
  205. Scottish Intercollegiate Guidelines Network . SIGN 50; A Guideline Developers' Handbook. Edinburgh: SIGN; 2001;Available from: http://www.sign.ac.uk/guidelines/fulltext/50/section7.html
  206. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ, et al. Users' guides to the medical literature. IX. A method for grading health care recommendations. JAMA. 1995;274:1800–1804(Erratum appears in JAMA 1996 Apr 24;275(16):1232)
  207. United States Department of Health and Human Services Agency for Health Care Policy and Research . Acute Pain Management; Operative or Medical Procedures and Trauma. Rockville, MD: AHCPR; 1993;p. 107 (Clinical practice guideline no. 1, AHCPR publication no. 92-0023)
  208. Hadorn DC, Baker D, Hodges JS, Hicks N. Rating and quality of evidence for clinical practice guidelines. J Clin Epidemiol. 1996;49:749–754
  209. Harbour R, Miller J. A new system for grading recommendations in evidence-based guidelines. BMJ. 2001;323:334–336
  210. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, et al. EULAR recommendations for the management of knee osteoarthritis; report of a task force of the Standing Committee for International Clinical Studies Including Clinical Trials (ESCISIT). Ann Rheum Dis. 2000;59:936–944
  211. Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrell F, et al. Evidence-based clinical guidelines: a new system to better determine true strength of recommendation. J Eval Clin Pract. 2005;12:347–352
  212. Glass GV. Primary, secondary, and meta-analysis of research. Educ Res. 1976;3:3–8
  213. Dreinhofer K, Stucki G, Ewert T, Huber E, Ebenbichier G, Gutenbrunner C, et al. ICF core sets for osteoarthritis. J Rehabil Med. 2004;(Suppl 44):75–80
  214. Boonen A, Rasker JJ, Stucki G. The international classification for functioning, disability and health. Clin Rheumatol. 2007;26:1803–1808
  215. WHO . WHO Business Plan for Classifications. Building Blocks of Health Information. Report no. v. 1.0 Geneva: World Health Organisation; 2005;
  216. Rintelen B, Neumann K, Leeb BF. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med. 2006;166:1899–1906
  217. Krueger K, Lino L, Dore R, Radominski S, Zhang Y, Kaur A, et al. Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II). Ann Rheum Dis. 2007 Oct 27;(Epub ahead of print)
  218. Nielsen OH, Ainsworth M, Csillag C, Rask-Madsen J. Systematic review: coxibs, non-steroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients?. Aliment Pharmacol Ther. 2006;23:27–33
  219. Scott PA, Kingsley GH, Smith CM, Choy EH, Scott DL. Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis. 2007;66:1296–1304
  220. Lequesne M, Berdah L, Gerentes I. Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis. Rev Prat. 1998;48(17 Suppl):S31–S35
  221. Nguyen M, Dougados M, Berdah L, Amor B. Diacerein in the treatment of osteoarthritis of the hip. Arthritis Rheum. 1994;37:529–536
  222. Pelletier J-P, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. Arthritis Rheum. 2000;43:2339–2348
  223. Louthrenoo W, Nilganuwong S, Aksaranugraha S, Asananatanabodee P, Saengnipanthkul S, Thai Study Group . The efficacy, safety, and carry over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled trial. Osteoarthritis Cartilage. 2007;15:605–614
  224. Hunter DJ, Wise B. Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis. Evid Based Med. 2007;12:74

PII: S1063-4584(07)00397-4

doi: 10.1016/j.joca.2007.12.013

Osteoarthritis and Cartilage
Volume 16, Issue 2 , Pages 137-162 , February 2008

Article Tools